DLK1与骨髓增生异常综合征骨髓衰竭的研究
81470295
2014
H0807.骨髓增生异常综合征
肖志坚
面上项目
主任医师
中国医学科学院
70万元
MDS;造血干细胞;骨髓间充质干细胞;骨髓衰竭;DLK1;骨髓增生异常综合征/
2015-01-01到2018-12-31
- 中英文摘要
- 结题摘要
- 结题报告
- 项目成果
- 项目参与人
查看更多信息请先登录或注册
查看更多信息请先登录或注册
查看更多信息请先登录或注册
| 序号 | 标题 | 类型 | 作者 |
|---|---|---|---|
| 1 | Colony-forming unit cell (CFU-C) assays at diagnosis: CFU-G/M cluster predicts overall survival in myelodysplastic syndrome patients independently of IPSS-R | 期刊论文 | Li B;Liu J;Qu S;Gale RP;Song Z;Xing R;Liu J;Ren Y;Xu Z;Qin T;Zhang Y;Fang L;Zhang H;Pan L;Hu N;Cai W;Zhang P;Huang G;Xiao Z |
| 2 | Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemia | 期刊论文 | Cui Y;Tong H;Du X;Li B;Gale RP;Qin T;Liu J;Xu Z;Zhang Y;Huang G;Fang L;Zhang H;Pan L;Hu N;Qu S;Xiao Z |
| 3 | 高嗜酸性粒细胞综合征及慢性嗜酸性粒细胞白血病的靶向测序研究 | 期刊论文 | 曲士强;秦铁军;徐泽锋;张悦;贾玉娇;艾小飞;张宏丽;方力维;胡耐博;潘丽娟;李冰;刘晋琴;汝昆;肖志坚 |
| 4 | HIF1A is a critical downstream mediator for hemophagocytic lymphohistiocytosis | 期刊论文 | Huang R;Hayashi Y;Yan X;Bu J;Wang J;Zhang Y;Zhou Y;Tang Y;Wu L;Xu Z;Liu X;Wang Q;Zhou J;Xiao Z;Bridges JP;Marsh RA;Zhang K;Jordan MB;Li Y;Huang G |
| 5 | Pathobiologic Pseudohypoxia as a Putative Mechanism Underlying Myelodysplastic Syndromes | 期刊论文 | Hayashi Y;Zhang Y;Yokota A;Yan X;Liu J;Choi K;Li B;Sashida G;Peng Y;Xu Z;Huang R;Zhang L;Freudiger GM;Wang J;Dong Y;Zhou Y;Wang J;Wu L;Bu J;Chen A;Zhao X;Sun X;Chetal K;Olsson A;Watanabe M;Romick-Rosendale LE;Harada H;Shih LY;Tse W;Bridges JP;Caligiuri MA;Huang T;Zheng Y;Witte DP;Wang QF;Qu CK;Salomonis N;Grimes HL;Nimer SD;Xiao Z;Huang G |
| 6 | Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia response | 期刊论文 | Xueping Luo;Zefeng Xu;Bing Li;Tiejun Qin;Peihong Zhang;Hongli Zhang;Liwei Fang;Naibo Hu;Shiqiang Qu;Yue Zhang;Gang Huang;Robert Peter Gale;Zhijian Xiao |
| 7 | 靶向测序检测511例骨髓增生异常综合征患者基因突变 | 期刊论文 | 李冰;王静雅;刘晋琴;史仲珣;彭帅玲;黄慧君;秦铁军;徐泽锋;张悦;方力维;张宏丽;胡耐博;潘丽娟;曲士强;肖志坚 |
| 8 | The usefulness of mutational data on prognosis of myelodysplastic syndromes: alone or incorporated into the IPSS-R? | 期刊论文 | Li B;Liu J;Xu Z;Qin T;Shi Z;Song Z;Huang H;Fang L;Zhang H;Pan L;Hu N;Qu S;Zhang Y;Huang G;Xiao Z |
| 9 | 环孢素联合沙利度胺治疗IPSS低危/中危-1骨髓增生异常综合征远期疗效影响因素分析 | 期刊论文 | 王静雅;秦铁军;徐泽锋;张悦;张宏丽;方力维;潘丽娟;胡耐博;曲士强;李冰;肖志坚 |
| 10 | A novel fusion of PDGFRB to TSC1, an intrinsic suppressor of mTOR-signaling pathway, in a chronic eosinophilic leukemia patient with t(5;9)(q32;q34) | 期刊论文 | Zhang Y;Qu S;Wang Q;Li J;Xu Z;Qin T;Huang G;Xiao Z |
| 11 | Tumor suppressor ASXL1 is essential for the activation of INK4B expression in response to oncogene activity and anti-proliferative signals | 期刊论文 | Wu X;Bekker-Jensen IH;Christensen J;Rasmussen KD;Sidoli S;Qi Y;Kong Y;Wang X;Cui Y;Xiao Z;Xu G;Williams K;Rappsilber J;Sønderby CK;Winther O;Jensen ON;Helin K |
| 12 | Expansion of EPOR-negative macrophages besides erythroblasts by elevated EPOR signaling in erythrocytosis mouse models | 期刊论文 | Wang J;Hayashi Y;Yokota A;Xu Z;Zhang Y;Huang R;Yan X;Liu H;Ma L;Azam M;Bridges JP;Cancelas JA;Kalfa TA;An X;Xiao Z;Huang G |
| 13 | Non-driver mutations in myeloproliferative neoplasm-associated myelofibrosis | 期刊论文 | Li B;Gale RP;Xu Z;Qin T;Song Z;Zhang P;Bai J;Zhang L;Zhang Y;Liu J;Huang G;Xiao Z |
| 14 | Clinical features and biological implications of different U2AF1 mutation types in myelodysplastic syndromes | 期刊论文 | Li B;Liu J;Jia Y;Wang J;Xu Z;Qin T;Shi Z;Song Z;Peng S;Huang H;Fang L;Zhang H;Pan L;Hu N;Qu S;Zhang Y;Wu J;Liu N;Ru K;Huang G;Xiao Z |
| 15 | TET2 mutations were predictive of inferior prognosis in the presence of ASXL1 mutations in patients with chronic myelomonocytic leukemia | 期刊论文 | Cui Y;Tong H;Du X;Li B;Gale RP;Qin T;Liu J;Xu Z;Zhang Y;Huang G;Jin J;Fang L;Zhang H;Pan L;Hu N;Qu S;Xiao Z |
| 16 | A systematic classification of megakaryocytic dysplasia and its impact on prognosis for patients with myelodysplastic syndromes | 期刊论文 | Feng G;Gale RP;Cui W;Cai W;Huang G;Xu Z;Qin T;Zhang Y;Li B;Fang L;Zhang H;Pan L;Hu N;Qu S;Wang J;Cui Y;Xiao Z |
查看更多信息请先登录或注册
